annual current liabilities:
$169.28M+$50.73M(+42.79%)Summary
- As of today (June 23, 2025), MDGL annual total current liabilities is $169.28 million, with the most recent change of +$50.73 million (+42.79%) on December 31, 2024.
- During the last 3 years, MDGL annual current liabilities has risen by +$92.44 million (+120.30%).
- MDGL annual current liabilities is now at all-time high.
Performance
MDGL Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$167.24M-$2.04M(-1.21%)Summary
- As of today (June 23, 2025), MDGL quarterly total current liabilities is $167.24 million, with the most recent change of -$2.04 million (-1.21%) on March 31, 2025.
- Over the past year, MDGL quarterly current liabilities has increased by +$52.90 million (+46.26%).
- MDGL quarterly current liabilities is now -5.97% below its all-time high of $177.85 million, reached on September 30, 2024.
Performance
MDGL quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
MDGL Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +42.8% | +46.3% |
| 3 y3 years | +120.3% | +118.2% |
| 5 y5 years | +573.6% | +550.6% |
MDGL Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +120.3% | -6.0% | +118.2% |
| 5 y | 5-year | at high | +573.6% | -6.0% | +550.6% |
| alltime | all time | at high | +4742.0% | -6.0% | +4871.4% |
MDGL Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $167.24M(-1.2%) |
| Dec 2024 | $169.28M(+42.8%) | $169.28M(-4.8%) |
| Sep 2024 | - | $177.85M(+42.1%) |
| Jun 2024 | - | $125.16M(+9.5%) |
| Mar 2024 | - | $114.34M(-3.5%) |
| Dec 2023 | $118.55M(+2.3%) | $118.55M(+18.9%) |
| Sep 2023 | - | $99.67M(-0.0%) |
| Jun 2023 | - | $99.71M(+1.4%) |
| Mar 2023 | - | $98.35M(-15.1%) |
| Dec 2022 | $115.89M(+50.8%) | $115.89M(+17.2%) |
| Sep 2022 | - | $98.92M(+17.7%) |
| Jun 2022 | - | $84.01M(+9.6%) |
| Mar 2022 | - | $76.64M(-0.3%) |
| Dec 2021 | $76.84M(+65.0%) | $76.84M(+10.8%) |
| Sep 2021 | - | $69.33M(+22.2%) |
| Jun 2021 | - | $56.71M(+16.2%) |
| Mar 2021 | - | $48.79M(+4.8%) |
| Dec 2020 | $46.56M(+85.3%) | $46.56M(-5.7%) |
| Sep 2020 | - | $49.37M(+9.0%) |
| Jun 2020 | - | $45.27M(+76.1%) |
| Mar 2020 | - | $25.70M(+2.3%) |
| Dec 2019 | $25.13M(+197.6%) | $25.13M(+62.5%) |
| Sep 2019 | - | $15.46M(+25.6%) |
| Jun 2019 | - | $12.32M(+17.8%) |
| Mar 2019 | - | $10.46M(+23.8%) |
| Dec 2018 | $8.44M(-16.0%) | $8.44M(+27.1%) |
| Sep 2018 | - | $6.64M(+22.2%) |
| Jun 2018 | - | $5.44M(-13.6%) |
| Mar 2018 | - | $6.29M(-37.4%) |
| Dec 2017 | $10.05M(+109.5%) | $10.05M(+18.0%) |
| Sep 2017 | - | $8.52M(+32.4%) |
| Jun 2017 | - | $6.44M(+9.0%) |
| Mar 2017 | - | $5.91M(+23.0%) |
| Dec 2016 | $4.80M(-90.3%) | $4.80M(+22.6%) |
| Sep 2016 | - | $3.92M(+16.4%) |
| Jun 2016 | - | $3.36M(-61.1%) |
| Mar 2016 | - | $8.64M(-82.5%) |
| Dec 2015 | $49.28M | $49.28M(+60.9%) |
| Sep 2015 | - | $30.63M(-5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $32.52M(+5.2%) |
| Mar 2015 | - | $30.92M(+0.1%) |
| Dec 2014 | $30.89M(-4.1%) | $30.89M(-6.3%) |
| Sep 2014 | - | $32.96M(+0.9%) |
| Jun 2014 | - | $32.67M(+0.9%) |
| Mar 2014 | - | $32.37M(+0.5%) |
| Dec 2013 | $32.21M(+37.1%) | $32.21M(+24.2%) |
| Sep 2013 | - | $25.93M(+29.2%) |
| Jun 2013 | - | $20.07M(+21.3%) |
| Mar 2013 | - | $16.55M(-29.5%) |
| Dec 2012 | $23.49M(+55.0%) | $23.49M(+23.8%) |
| Sep 2012 | - | $18.96M(+3.9%) |
| Jun 2012 | - | $18.25M(+16.7%) |
| Mar 2012 | - | $15.64M(+3.3%) |
| Dec 2011 | $15.15M(-9.5%) | $15.15M(-11.5%) |
| Sep 2011 | - | $17.12M(+11.5%) |
| Jun 2011 | - | $15.35M(-11.3%) |
| Mar 2011 | - | $17.31M(+3.5%) |
| Dec 2010 | $16.74M(+1.6%) | $16.74M(+12.0%) |
| Sep 2010 | - | $14.95M(+21.9%) |
| Jun 2010 | - | $12.27M(-5.9%) |
| Mar 2010 | - | $13.04M(-20.8%) |
| Dec 2009 | $16.47M(-50.6%) | $16.47M(-7.3%) |
| Sep 2009 | - | $17.76M(-87.9%) |
| Jun 2009 | - | $146.36M(+240.8%) |
| Mar 2009 | - | $42.95M(+28.9%) |
| Dec 2008 | $33.32M(+60.4%) | $33.32M(+22.3%) |
| Sep 2008 | - | $27.24M(+31.4%) |
| Jun 2008 | - | $20.72M(+1.0%) |
| Mar 2008 | - | $20.52M(-1.2%) |
| Dec 2007 | $20.77M(+79.9%) | $20.77M(+50.3%) |
| Sep 2007 | - | $13.82M(-12.9%) |
| Jun 2007 | - | $15.87M(+29.1%) |
| Mar 2007 | - | $12.29M(+6.5%) |
| Dec 2006 | $11.55M(-20.2%) | $11.55M(-0.1%) |
| Sep 2006 | - | $11.55M(-20.2%) |
| Dec 2005 | $14.47M(+12.4%) | $14.47M(-8.6%) |
| Mar 2005 | - | $15.83M |
| Dec 2004 | $12.88M(+268.3%) | - |
| Dec 2003 | $3.50M | - |
FAQ
- What is Madrigal Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals annual current liabilities year-on-year change?
- What is Madrigal Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly current liabilities year-on-year change?
What is Madrigal Pharmaceuticals annual total current liabilities?
The current annual current liabilities of MDGL is $169.28M
What is the all time high annual current liabilities for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual total current liabilities is $169.28M
What is Madrigal Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, MDGL annual total current liabilities has changed by +$50.73M (+42.79%)
What is Madrigal Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of MDGL is $167.24M
What is the all time high quarterly current liabilities for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly total current liabilities is $177.85M
What is Madrigal Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, MDGL quarterly total current liabilities has changed by +$52.90M (+46.26%)